Cargando…

Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2

Aberrant expression of splicing factors was found to promote tumorigenesis and the development of human malignant tumors. Nevertheless, the underlying mechanisms and functional relevance remain elusive. We here show that USP39, a component of the spliceosome, is frequently overexpressed in high-grad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shourong, Wang, Zixiang, Li, Jieyin, Qin, Junchao, Song, Jianping, Li, Yingwei, Zhao, Ling, Zhang, Xiyu, Guo, Haiyang, Shao, Changshun, Kong, Beihua, Liu, Zhaojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969951/ https://www.ncbi.nlm.nih.gov/pubmed/33731694 http://dx.doi.org/10.1038/s41419-021-03581-3

Ejemplares similares

MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2
por: Tian, Xiaoxue, et al.
Publicado: (2020)

Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12
por: Wang, Zixiang, et al.
Publicado: (2022)

Spliceosome component Usp39 contributes to hepatic lipid homeostasis through the regulation of autophagy
por: Cui, Donghai, et al.
Publicado: (2023)

SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52
por: Diao, Yuchao, et al.
Publicado: (2022)

The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5
por: Li, Yingwei, et al.
Publicado: (2022)

Overexpression of HMGA1 confers radioresistance by transactivating RAD51 in cholangiocarcinoma
por: Song, Jianping, et al.
Publicado: (2021)

RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation
por: Ding, Kaikai, et al.
Publicado: (2019)

Rad50 promotes ovarian cancer progression through NF‐κB activation
por: Li, Yinuo, et al.
Publicado: (2021)

USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC
por: Zheng, Jingyi, et al.
Publicado: (2023)

The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor
por: Zhu, Xiaolin, et al.
Publicado: (2022)

Zebrafish usp39 Mutation Leads to rb1 mRNA Splicing Defect and Pituitary Lineage Expansion
por: Ríos, Yesenia, et al.
Publicado: (2011)

The Deubiquitinase USP39 Promotes ESCC Tumorigenesis Through Pre-mRNA Splicing of the mTORC2 Component Rictor
por: Zhao, Yuan, et al.
Publicado: (2021)

Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25
por: Valero, Rebeca, et al.
Publicado: (2001)

Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
por: LeFave, Clare V, et al.
Publicado: (2011)

Deubiquitinase USP47-stabilized splicing factor IK regulates the splicing of ATM pre-mRNA
por: Ka, Hye In, et al.
Publicado: (2020)

Mitochondrial superoxide contributes to oxidative stress exacerbated by DNA damage response in RAD51-depleted ovarian cancer cells
por: Xu, Limei, et al.
Publicado: (2020)

Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer
por: Lo, April, et al.
Publicado: (2022)

An NAD(+)-Dependent Deacetylase SIRT7 Promotes HCC Development Through Deacetylation of USP39
por: Dong, Ling, et al.
Publicado: (2020)

SpliceFinder: ab initio prediction of splice sites using convolutional neural network
por: Wang, Ruohan, et al.
Publicado: (2019)

Oncogenes and RNA splicing of human tumor viruses
por: Ajiro, Masahiko, et al.
Publicado: (2014)

USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1
por: Das, Tanuza, et al.
Publicado: (2022)

c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer
por: Caggiano, Cinzia, et al.
Publicado: (2019)

Phosphorylation of USP27X by GSK3β maintains the stability and oncogenic functions of CBX2
por: Xing, Yushu, et al.
Publicado: (2023)

The Molecular Mechanisms of Regulation on USP2's Alternative Splicing and the Significance of Its Products
por: Zhu, Han-Qing, et al.
Publicado: (2017)

Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1
por: Zhao, Chen, et al.
Publicado: (2021)

Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1
por: Du, Jun-Xian, et al.
Publicado: (2021)

USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A(165b) alternative splicing via regulating SRSF1 and SRPK1
por: Pan, Xiu-wu, et al.
Publicado: (2021)

Splicing is an alternate oncogenic pathway activation mechanism in glioma
por: Siddaway, Robert, et al.
Publicado: (2022)

Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer
por: Hou, Dong, et al.
Publicado: (2018)

HMGA1a Induces Alternative Splicing of the Estrogen Receptor-αlpha Gene by Trapping U1 snRNP to an Upstream Pseudo-5′ Splice Site
por: Ohe, Kenji, et al.
Publicado: (2018)

Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis
por: D’Angelo, Daniela, et al.
Publicado: (2019)

Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors
por: Piekielko-Witkowska, Agnieszka, et al.
Publicado: (2010)

RAD51 is essential for spermatogenesis and male fertility in mice
por: Qin, Junchao, et al.
Publicado: (2022)

Alternative Splicing in Oncogenic Kinases: From Physiological Functions to Cancer
por: Druillennec, Sabine, et al.
Publicado: (2012)

Increased levels of noisy splicing in cancers, but not for oncogene-derived transcripts
por: Chen, Lu, et al.
Publicado: (2011)

Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene
por: Moon, Heegyum, et al.
Publicado: (2015)

Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors
por: Bielli, Pamela, et al.
Publicado: (2019)

Splicing and alternative splicing in rice and humans
por: E, Zhiguo, et al.
Publicado: (2013)

Spliced or Unspliced, That Is the Question: The Biological Roles of XBP1 Isoforms in Pathophysiology
por: Luo, Xinxin, et al.
Publicado: (2022)

Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation
por: Jia, Rong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p2duavh1kfus0odr4sn3u5en6n